We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

76 hedge funds and large institutions have $101M invested in AVEO Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

68% more capital invested

Capital invested by funds: $60.4M → $101M (+$40.9M)

38% more call options, than puts

Call options by funds: $7.28M | Put options by funds: $5.28M

17% more funds holding

Funds holding: 65 → 76 (+11)

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

Holders
76
Holders Change
+11
Holders Change %
+16.92%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
21
Reduced
19
Closed
9
Calls
$7.28M
Puts
$5.28M
Net Calls
+$2M
Net Calls Change
+$2.03M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$12.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.32M
3
OM
Opaleye Management
Massachusetts
+$6.7M
4
CCP
Clough Capital Partners
Massachusetts
+$2.59M
5
MIM
Monashee Investment Management
Massachusetts
+$2.16M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$9.71M
2
JP Morgan Chase
JP Morgan Chase
New York
-$837K
3
Squarepoint
Squarepoint
New York
-$745K
4
Millennium Management
Millennium Management
New York
-$630K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$619K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
51
Sabby Management
Florida
$79K -$494K -57,277 -84%
VOYA Investment Management
52
VOYA Investment Management
Georgia
$76K – – –
MOS
53
MGO One Seven
Ohio
$73K – – –
LCM
54
Laurion Capital Management
New York
$73K +$86.3K +10,000 New
Wells Fargo
55
Wells Fargo
California
$65K -$269K -31,232 -78%
JP Morgan Chase
56
JP Morgan Chase
New York
$60K -$837K -96,978 -92%
EP
57
Eudaimonia Partners
Tennessee
$48K +$57.1K +6,624 New
TRCT
58
Tower Research Capital (TRC)
New York
$45K +$13K +1,502 +33%
GAM
59
Gemmer Asset Management
California
$28K – – –
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$20K -$7.53K -873 -25%
Legal & General Group
61
Legal & General Group
United Kingdom
$16K -$1.61K -187 -8%
Osaic Holdings
62
Osaic Holdings
Arizona
$14K +$5.9K +684 +56%
AIP
63
Ameritas Investment Partners
Nebraska
$13K +$5.52K +640 +53%
Citigroup
64
Citigroup
New York
$11K -$23K -2,666 -65%
TFS
65
TrustCore Financial Services
Tennessee
$11K – – –
Rockefeller Capital Management
66
Rockefeller Capital Management
New York
$11K +$13.8K +1,600 New
UBS Group
67
UBS Group
Switzerland
$9K -$48.2K -5,589 -83%
PAM
68
Panagora Asset Management
Massachusetts
$9K – – –
EWM
69
Edge Wealth Management
New York
$7K – – –
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
$5K -$23.8K -2,760 -81%
LFG
71
Larson Financial Group
Missouri
$4K – – –
WIM
72
Westside Investment Management
California
$3.66K – – –
AF
73
Advisornet Financial
Minnesota
$1K – – –
AIG
74
American International Group
New York
$93 +$285 +33 +0.3%
TI
75
Trexquant Investment
Connecticut
– -$374K -64,838 Closed
1 2
3
4

AVEO Hedge Fund Activity: Q1 2021 in Review

76 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2021, worth a combined $101M — up 68% from $60.4M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new AVEO positions and 9 closed out — a net gain of 11 holders — while 21 added to existing stakes and 19 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $12.9M. The largest seller was Sectoral Asset Management, cutting an estimated $9.71M.

  • 76 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2021, up from 65 in Q4 2020.
  • Funds reported $101M of AVEO Pharmaceuticals, Inc. stock for Q1 2021, up 68% quarter-over-quarter.
  • 20 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2021 and 9 closed out, a net change of +11 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2021 was Cormorant Asset Management, an estimated $12.9M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q1 2021 was Sectoral Asset Management, an estimated $9.71M sold.

Based on aggregated 13F filings for Q1 2021.